1-4 of 4
Nelofer Syed
Close
Sort by
Journal Articles

Epigenetic Inactivation Targets the Arginine Biosynthetic Pathway At Two Levels in Multiple Myeloma

Eleftheria Hatzimichael, Aggeliki Dasoula, Nelofer Syed, Peter Szlosarek, George Dranitsaris, Tim Crook, Evangelos Briasoulis
Journal: Blood
Blood (2011) 118 (21): 4640.
https://doi.org/10.1182/blood.V118.21.4640.4640
Published: 2011
Journal Articles

Snk/Plk2 Methylation Is a Frequent Event in Patients with Multiple Myeloma

Eleftheria Hatzimichael, George Dranitsaris, Aggeliki Dasoula, Nelofer Syed, Justin Stebbing, Tim Crook, Konstantinos Bourantas
Journal: Blood
Blood (2008) 112 (11): 4479.
https://doi.org/10.1182/blood.V112.11.4479.4479
Published: 2008
Journal Articles

Epigenetic Profiling Identifies EGLN3 as a Frequent Target for Transcriptional Silencing in Plasma Cell Neoplasias.

Reshma Shah, Eleftheria Hatzimichael, MD, Nelofer Syed, PhD, Konstantinos L. Bourantas, MD, PhD, Tim Crook, MRCP, PhD
Journal: Blood
Blood (2007) 110 (11): 2132.
https://doi.org/10.1182/blood.V110.11.2132.2132
Published: 2007
Journal Articles

Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies

Nelofer Syed, Paul Smith, Alexandra Sullivan, Lindsay C. Spender, Martin Dyer, Lorraine Karran, Jenny O'Nions, Martin Allday, Ingrid Hoffmann, Dorothy Crawford, Beverley Griffin, Paul J. Farrell, Tim Crook
Journal: Blood
Blood (2006) 107 (1): 250–256.
https://doi.org/10.1182/blood-2005-03-1194
Published: 2006